State of Tennessee, Department of Treasury
Position in EXEL — Exelixis, Inc.
CIK 1587973
NASHVILLE, TN
Position in EXEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,133,975
-$112,519 QoQ
Shares Held
119,701
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026State of Tennessee, Department of Treasury holds $125,190,066 across 33 Biotechnology names. EXEL ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,668 | $36,468,028 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,458 | $32,032,109 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
29,581 | $5,592,288 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
91,261 | $5,155,333 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
119,701 | $5,133,975 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
57,516 | $3,717,259 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
129,274 | $3,580,889 | |
| 8 | INCY |
Incyte Corp
|
37,020 | $3,484,322 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,133,975 | 119,701 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,246,494 | 119,701 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $5,220,526 | 126,405 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,247,108 | 96,350 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,754,764 | 101,700 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,970,326 | 89,199 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,380,030 | 91,716 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,235,338 | 99,481 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,559,500 | 150,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,734,883 | 114,001 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,777,886 | 172,901 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,452,718 | 180,676 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,921,871 | 253,574 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,332,869 | 270,129 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,235,622 | 270,129 | Shares | Sole | 2023-01-26 | |
| 2022-06-30 | $8,115,719 | 389,804 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,703,356 | 339,804 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,555,617 | 139,804 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,687,056 | 79,804 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,525,442 | 193,493 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,371,006 | 193,493 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,800,106 | 139,517 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $6,058,489 | 247,791 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,407,758 | 227,791 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,204,659 | 244,173 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||